90
Participants
Start Date
November 30, 2014
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
PF-06372865.
Blinded PF 06372865 and matching placebo will be provided as tablets for oral administration.
Fieve Clinical Research, Inc, New York
Bioscience Research LLC, Mount Kisco
SPRI Clinical Trials LLC, Brooklyn
Comprehensive Clinical Development, Inc., Jamaica
Neurobehavioral Research, Inc., Cedarhurst
Suburban Research Associates, Media
Pharmasite Research Inc, Baltimore
Institute for Advanced Medical Research, Alpharetta
Northwest Behavioral Research Center, Roswell
Atlanta Center for Medical Research, Atlanta
Sarkis Clinical Trials, Lake City
Clinical Neuroscience Solutions, Inc., Jacksonville
Sarkis Clinical Trials, Gainesville
Avail Clinical Research, LLC, DeLand
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions, Inc., Orlando
Berma Research Group, Hialeah
Stedman Clinical Trials, Tampa
Gulfcoast Clinical Center, Fort Meyers
Clinical Neuroscience Solutions, Inc., Memphis
Patient Priority Clinical Sites, LLC, Cincinnati
CTI Clinical Research Center, Cincinnati
Great Lakes Clinical Trials, Chicago
Phoenix Medica Research, Inc, Prairie Village
Premier Psychiatric Research Institute. LLC., Lincoln
Cutting Edge Research Group, Oklahoma City
InSite Clinical Research, LLC, DeSoto
Futuresearch Trials of Dallas, Dallas
Family Psychiatry of The Woodlands, The Woodlands
Comprehensive Clinical Development, Inc., Cerritos
Pharmacology Research Institute, Encino
Pacific Clinical Research Medical Group, Upland
Excell Research, Inc., Oceanside
California Neuorpsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC), San Diego
Artemis Institute for Clinical Research, San Diego
Sun Valley Research Center, Imperial
NRC Research Institute, Orange
Summit Research Network (Oregon) Inc., Portland
Northwest Clinical Research Center, Bellevue
Summit Research Network (Seattle) LLC, Seattle
Hartford Hospital, Hartford
Institute of Living, Hartford
Beacon Clinical Research, LLC, Brockton
ActivMed Practices & Research, Inc, Methuen
BCCR Trials, Natick
Center for Emotional Fitness, Cherry Hill
Bio Behavioral Health, Toms River
Lead Sponsor
Pfizer
INDUSTRY